Although increased infiltration of CD3+CD4+ and CD3+CD8+ T cells was seen in both responders' and non-responders' biopsy samples, expression of CD39, a surrogate marker of tumor-reactive CD8+ cells, was elevated only in patients with pathological CR. This evidence concerns the gene CD8A and neoplasm.